4-(2-amino-1,3-benzothiazol-4-yl)-1-N-[(2S)-1-aminopropan-2-yl]-3-(2H-tetrazol-5-yl)benzene-1,2-disulfonamide

InChIKey	`VTIMNZCVMMQWBP-QMMMGPOBSA-N`
Compound Name	4-(2-amino-1,3-benzothiazol-4-yl)-1-N-[(2S)-1-aminopropan-2-yl]-3-(2H-tetrazol-5-yl)benzene-1,2-disulfonamide
Canonical SMILES	`C[C@@H](CN)NS(=O)(=O)c1ccc(-c2cccc3sc(N)nc23)c(-c2nn[nH]n2)c1S(N)(=O)=O`
Clinical Status	Data-mined Candidate
Targets (Human+Pathogen)	3
Pfam Stratification	Cross-Family
Avg pChEMBL	9.14
Source	BindingDB

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
C7C422	blaNDM-1	Klebsiella pneumoniae	Pathogen	PF00753	9.5	IC50	BindingDB
Q2QC95	blaoxa-10	Klebsiella pneumoniae	Pathogen	PF00905	9.1	IC50	BindingDB
P52699		Serratia marcescens	Pathogen	PF00753	8.7	IC50	BindingDB